EXAGEN INC. - COMMON STOCK
3.1700
10-January-25 16:45:00
15 minutes delayed
Stocks
-0.1200
-3.65%
Today's range
3.0500 - 3.3100
ISIN
N/A
Source
NASDAQ
-
Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results
22 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Announces New Rheumatoid Arthritis Scientific Advisory Board
16 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
09 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 22, 2022
08 Mar 2022 16:05:00 By Nasdaq GlobeNewswire
-
02 Feb 2022 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
17 Nov 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports Third Quarter 2021 Results
10 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
04 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021
27 Oct 2021 16:05:01 By Nasdaq GlobeNewswire
-
27 Oct 2021 08:25:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Announces $27.2 Million Debt Refinancing
25 Oct 2021 08:25:00 By Nasdaq GlobeNewswire
-
Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021
21 Oct 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
13 Sep 2021 16:15:00 By Nasdaq GlobeNewswire
-
Exagen Inc. Reports Second Quarter 2021 Results
09 Aug 2021 16:05:01 By Nasdaq GlobeNewswire
-
Exagen Appoints Ana Hooker to Board of Directors
30 Jul 2021 08:25:00 By Nasdaq GlobeNewswire
-
Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
29 Jul 2021 08:25:00 By Nasdaq GlobeNewswire
-
Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021
26 Jul 2021 16:05:56 By Nasdaq GlobeNewswire
-
13 Jul 2021 16:05:00 By Nasdaq GlobeNewswire
-
Exagen Elects Frank Stokes to Board of Directors
18 Jun 2021 08:29:00 By Nasdaq GlobeNewswire